Andreas Halvorsen’s LianBio American Depositary Shares LIAN Stock Holding History

Andreas Halvorsen’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,564,173	Closed	-$15.9M	–	99
2023 Q4	$15.9M	Hold	3,564,173	–	–	0.06%	75
2023 Q3	$5.31M	Hold	3,564,173	–	–	0.02%	78
2023 Q2	$8.13M	Hold	3,564,173	–	–	0.03%	84
2023 Q1	$6.95M	Hold	3,564,173	–	–	0.03%	78
2022 Q4	$5.85M	Hold	3,564,173	–	–	0.03%	74
2022 Q3	$7.09M	Hold	3,564,173	–	–	0.03%	87
2022 Q2	$7.7M	Buy	3,564,173 +2,064,173	+138%	+$7.01M	0.04%	82
2022 Q1	$5.57M	Hold	1,500,000	–	–	0.02%	89
2021 Q4	$9.24M	Buy	+1,500,000	New	+$17.1M	0.03%	105

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Andreas Halvorsen's LIAN Position: Q1 2024 in Review

Andreas Halvorsen sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 3,564,173 shares — an estimated $15.9M sold.

Andreas Halvorsen first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $15.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Andreas Halvorsen reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Andreas Halvorsen sold 3,564,173 LianBio American Depositary Shares shares in Q1 2024, an estimated $15.9M.
Andreas Halvorsen first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
Andreas Halvorsen's LianBio American Depositary Shares position peaked at $15.9M in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Viking Global Investors's 13F filing for Q1 2024, filed 15 May 2024.